If Davide Campari-Milano was on your watchlist rather than in your portfolio, the recent move may feel like a missed shot. Investors who held Davide Campari-Milano from the start of the year are up 25.7%, including dividends. Back on 1 January 2026, analysts were split between global expansion upside and the risk that slowing alcohol consumption and tariffs would bite. If you had focused on those conflicting demand and margin assumptions, would this return have looked plausible enough to act on?
If the move has made Davide Campari-Milano harder to judge, start where the gap is still open and scan 196 high quality undervalued stocks.
The shares cost €5.53 at the start of the period, and buyers had to decide which of two very different stories about Davide Campari-Milano felt more convincing.
The optimistic script pointed to global expansion and premiumisation, with one Narrative arguing for a Fair Value of €6.75, the price that view implied if revenue grew 4.5% a year and margins rose toward 13.6%.
The cautious view focused on weaker alcohol demand and higher regulation, with a Fair Value of €4.2 built on 2.1% annual revenue growth and profit margins reaching 11.8%.
Q1 2026 organic sales growth of 2.9% at Davide Campari-Milano, alongside reaffirmed guidance of about 3% for the year, lent some support to the more optimistic expansion story. The later H1 2026 figures pulled the other way. Revenue slipped from €1,528m to €1,512m, net income dropped from €206m to €129m, and net margin compressed from 13.5% to 8.5%, which backed the cautious case. Overall, the evidence cut both ways.
The hinge assumption here was that growth and margin expansion would arrive together. When you assess another consumer stock, line up any upbeat volume story directly against reported net margin, not just revenue, to see whether profitability is keeping pace with the growth pitch.
Davide Campari-Milano now trades at €6.82, after a 25.7% gain from the start of the year. The bearish analyst Narrative on Simply Wall St sees its Fair Value below that level and argues the current tag already prices in solid progress on growth, mix and profitability.
This Narrative highlights category softness, cost pressure and reliance on developing markets as the key pressure points. Anyone paying today’s price is effectively assuming margin strength and organic expansion hold up. The real question is how those concrete risks affect the odds of that playing out.
"The current valuation implies the share price already reflects continued organic growth, margin accretion and developing-market expansion, which leaves limited room for disappointment if category, tariff or cost risks affect earnings."
One Narrative disagrees with today's price. → See where this Narrative says Davide Campari-Milano should trade
Seeing Campari move raises a natural follow up. Where else are drink brands trying to solve similar problems?
One large spirits group is reshaping itself around higher margin beer, spirits and ready to drink products. It is also working to cut overheads and free up more cash from its operations.
Management there is spending heavily to expand a flagship stout brand and modernize plants. At the same time, it is rolling out data tools to shift inventory toward stronger demand.
The same moderation trends that worry Campari also matter for that business. What interests some investors is how disciplined cost work and product mix could change its role in global alcohol over time.
That argument has a Narrative and a number behind it. → See the company one Narrative values 30% above its price
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com